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Protein interactions between acyl carrier proteins
(ACPs) and trans-acting acyltransferase domains
(trans-ATs) are critical for regioselective extender
unit installation by many polyketide synthases, yet
little is known regarding the specificity of these inter-
actions, particularly for trans-ATs with unusual
extender unit specificities. Currently, the best-stud-
ied trans-AT with nonmalonyl specificity is KirCII
from kirromycin biosynthesis. Here, we developed
an assay to probe ACP interactions based on
leveraging the extender unit promiscuity of KirCII.
The assay allows us to identify residues on the ACP
surface that contribute to specific recognition by
KirCII. This information proved sufficient to modify
a noncognate ACP from a different biosynthetic
system to be a substrate for KirCII. The findings
form a foundation for further understanding the
specificity of trans-AT:ACP protein interactions and
for engineering modular polyketide synthases to
produce analogs.
INTRODUCTION
The scaffolds of a variety of clinically relevant natural products
are biosynthesized by polyketide synthases (PKSs). Type I
PKSs are organized in a modular fashion, whereby each module
is responsible for the installation of an extender unit acyl-
coenzyme A (CoA) into the growing polyketide (Staunton and
Weissman, 2001). The growing chain and all other substrates
are covalently tethered to the phosphopantetheinyl prosthetic
arm of acyl carrier proteins (ACPs), located within each module.
Acyltransferase (AT) domains are required to select extender
units and attach them to an ACP, whereas ketosynthase (KS)
domains catalyze C-C bond formation to extend the growing
polyketide. Modifications to this basic paradigm can be found
in natural biosynthetic systems. For example, fungal PKSs are
type I PKSs that act iteratively, whereby a given module cata-
lyzes several extender unit installations (Cox and Simpson,
2009). In most type I PKSs, the AT domains are embeddedwithin636 Chemistry & Biology 21, 636–646, May 22, 2014 ª2014 Elseviereach module and are cis-acting. In contrast, a growing number
of PKSs are being discovered that house ATs external to the
modules (Cheng et al., 2003; Piel, 2010). Such trans-acting ATs
(trans-ATs) at the genetic level can be easily transferred between
biosynthetic systems. Subsequently, given their discrete nature,
trans-ATs might constitute a valuable alternative to strategies
that involve cis-acting AT (cis-AT) domain swapping, and there
is much interest in developing trans-ATs for use as tools in
synthetic biology platforms aimed at the regioselectivemodifica-
tion of polyketides (Kumar et al., 2003; Walker et al., 2013). For
example, promiscuity of KSs from the 6-deoxyerythronolide
synthase (DEBS) toward diverse extender units (Koryakina
et al., 2013a; Sundermann et al., 2013) could be harnessed by
trans-ATs that display acyl-CoA specificity orthogonal to that
of the DEBS cis-AT domains, yet one critical barrier to the use
of trans-ATs as tools for polyketide diversification is our poor
understanding of extender unit and ACP specificity. For
example, the native substrate for many trans-ATs is malonyl-
CoA (Figure 1), and these enzymes are unlikely to display activity
toward other acyl-CoAs (Koryakina et al., 2013b). Furthermore,
whereas some trans-ATs that use malonyl-CoA install the
extender unit at multiple positions within the resulting polyketide
and are ACP promiscuous (Wong et al., 2010), others install
unusual extenders at limited positions in the polyketide and are
likely ACP specific (Figure 1) (Liu et al., 2009; Musiol et al.,
2011; Zhao et al., 2010). Thus, the ACP specificity of trans-ATs
needs to be better understood so that specificity can be manip-
ulated. Although evidence of the ability to manipulate ACP inter-
actions with other domains is emerging (Haines et al., 2013;
Kapur et al., 2010, 2012), little is known regarding trans-AT:ACP
interactions. Indeed, including the malonyl-CoA-ACP transacy-
lase (MCAT) that primarily serves ACPs from type II fatty acid
synthases, only two trans-AT structures are available (Kea-
tinge-Clay et al., 2003; Wong et al., 2011), in addition to that of
a bifunctional trans-AT/decarboxylase (Lohman et al., 2013).
Docking models have helped propose the ACP interaction epi-
topes of MCAT and at least one genuine malonyl-CoA specific
trans-AT (Arthur et al., 2009; Keatinge-Clay et al., 2003; Wong
et al., 2011), and NMR studies have also contributed to this
picture (Arthur et al., 2009).
Recently, we probed the promiscuity of several trans-ATs
toward a panel of acyl-CoAs (Koryakina et al., 2013b). One
target, KirCII from kirromycin biosynthesis (Figure 2), is respon-
sible for installation of the C28 ethyl moiety of kirromycin, viaLtd All rights reserved
Figure 1. Substrate Specificity of Trans-
ATs
(A) Examples of polyketides biosynthesized via
trans-ATs. The contribution of each trans-AT and
the corresponding substrate are shown color
coded.
(B) Examples of acyl-thioester substrates for
trans-ATs.
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of being the only characterized trans-AT to naturally utilize a
nonmalonyl acyl-CoA substrate (Musiol and Weber, 2012). All
other unusual trans-AT extender units are introduced into poly-
ketides linked to ACPs (Figure 1). Our study led to the discovery
that in addition to ethylmalonyl-CoA, KirCII can utilize other acyl-
CoAs, making KirCII the most promiscuous trans-AT known.
Kirromycin biosynthesis involves the action of another trans-AT
(KirCI) responsible for malonyl installation onto ACPs within 11
unique modules of the kirromycin biosynthetic assembly line
(Musiol et al., 2013). According to this biosynthetic logic, it is
likely that the acyl-CoA and ACP specificity of KirCII is orthog-
onal to that of KirCI. This feature would present a valuable oppor-
tunity to elucidate the molecular basis for ACP specificity of a
uniquely acyl-CoA promiscuous trans-AT. Here, we describe
a cycloaddition assay to rapidly characterize and probe
KirCII:ACP interactions, which led to characterization of the
ACP specificity of KirCII and promoted identification of the
KirCII:ACP interaction epitope. This information allowed us to
successfully convert a noncognate ACP into a substrate for
KirCII via a single amino acid mutation. The insight into trans-
AT:ACP interactions obtained here will contribute to improving
trans-AT-based strategies for polyketide diversification.
RESULTS
Cycloaddition Assay for Probing KirCII:ACP Interactions
The ability of KirCII to utilize extender unit acyl-CoAs modified
with azide/alkynyl functionality could enable the quantification
of KirCII activity via bioorthogonal ligation chemistry and in-gel
fluorescence detection (Figure 3A). In-gel fluorescence detec-
tion of KirCII-catalyzed trans-acylation of holo-ACP5Kir was eval-Chemistry & Biology 21, 636–646, May 22, 2014uated using azidoethylmalonyl-CoA
(AzEM-CoA) as substrate and strain-
promoted azide-alkyne cycloaddition
using a commercially available dibenzo-
cyclooctyne (DIBO)-Alexa Fluor 647 con-
jugate. Upon fluorescence visualization
of a SDS-PAGE gel, a distinct band was
observed at a position corresponding to
the loaded ACP5Kir (Figure 3B). In the
absence of KirCII, acyl-CoA, or cyclo-
octyne-fluorophore, only background
signal was detected. As expected, activ-
ity was not detected when apo-ACP5Kir
was used in place of holo-ACP5Kir.
Furthermore, Sfp was used to transfer
the azido-functionalized phosphopan-
tetheine moiety from AzEM-CoA to apo-ACP5Kir, resulting in strong labeling with the cyclooctyne-
fluorophore (Figure 3B). Next, the fluorescence intensity of the
labeled ACP bands was quantified by in-gel fluorescence
analysis. Inclusion of the MCAT from Streptomyces coelicolor
or the malonyl-CoA trans-AT from the disorazole synthase
(DSZS), which cannot utilize AzEM-CoA, in place of KirCII failed
to produce labeled ACP (Figure 3C). In addition, the fluorescence
intensity was shown to be dependent on the KirCII reaction incu-
bation time (Figure 3D) and the concentration of KirCII (Fig-
ure 3E). Cumulatively, these data show that AzEM-CoA and
cycloaddition enable the rapid and efficient quantification of
KirCII activity.
ACP Specificity of KirCII
Previous studies led to the conclusion that KirCII is responsible
for installation of the C29-ethyl moiety in kirromycin (Musiol
et al., 2011). Given the presence of another trans-AT in the kirro-
mycin biosynthetic gene cluster, we set out to investigate
whether KirCII displays specificity for ACP5Kir or whether KirCII
could potentially interact with other ACPs from kirromycin
biosynthesis. Each kirromycin ACP was subcloned into an
expression plasmid as an N-terminal His6-tagged fusion protein,
fully converted to the holo-ACP, and subsequently purified to
homogeneity (see Supplemental Information available online).
The conversion of each apo-ACP to the holo-form was moni-
tored by liquid chromatography-mass spectrometry (MS) anal-
ysis of the reaction mixtures, which indicated that in every
case, conversion was 100% (Figure S1). Each holo-ACP was
then tested as a substrate for KirCII-catalyzed trans-acylation
using AzEM-CoA (Figure 4). In this assay, ACP5Kir supported
the highest activity with KirCII, although ACP0Kir, ACP3Kir, and
ACP7Kir supported basal activity at 15%–25% of ACP5Kir. Theª2014 Elsevier Ltd All rights reserved 637
Figure 2. Biosynthesis of Kirromycin
The putative biosynthetic contribution of KirCI (malonyl-CoA, red) and KirCII (ethylmalonyl-CoA, purple) to the final structure of kirromycin is highlighted.
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<10% of ACP5Kir. These data suggest that ACP5Kir is the
preferred interaction partner for KirCII, and other kirromycin
ACPs are poor substrates for KirCII. The ACP specificity of KirCII
supports a role for programmed protein interactions in mainte-
nance of kirromycin biosynthetic fidelity.
Mapping the KirCII:ACP5Kir Interaction Epitope
The ACP specificity of KirCII led us to speculate that ACP5Kir
interacts with KirCII through a set of unique residues at the
ACP surface. Accordingly, we set out to map this epitope via
alanine scanning mutagenesis. In order to identify residues
predicted to be surface exposed, a homology model for ACP5Kir
was constructed using the SWISS-MODEL workspace and the
apo-D-alanyl carrier protein as template (Protein Data Bank
code 1DV5) (see Experimental Procedures for details). A total
of 61 (non-Ala/Gly) surface residues were then individually
mutated to Ala, expressed, subjected to Sfp-mediated phospho-
pantetheinylation, and purified. Notably, three of these mutants,
D64A, L66A, and I83A, could not be completely converted to
the holo-form, whereas L52A, L58A, Y79A, F88A, and T93A
could not be expressed in soluble form. D64 and L66 are imme-
diately adjacent to the presumed phosphopantetheinylation site
(S65), and mutations at this position in other ACPs are known to
hinder modification by Sfp (Weissman et al., 2006). The I83A
mutant is largely unfolded, as judged by analysis of the corre-638 Chemistry & Biology 21, 636–646, May 22, 2014 ª2014 Elseviersponding CD spectrum. Thus, these eight mutants were omitted
from further analysis. TheCD spectra of a representative panel of
the ACP5Kir mutants matched very closely to that of wild-type
(WT) ACP5Kir, indicating similar secondary structures (Figure S2).
Next, each ACP5Kir mutant was tested as a substrate for KirCII
using AzEM-CoA and the cycloaddition assay. Many of the mu-
tants displayed activity similar toWTACP5Kir, indicating that mu-
tation to Ala at these positions does not significantly impact
interaction with KirCII (Figure 5A). However, substitution at five
positions (H44, L45, R51, D60, and R70) resulted in activities
<20% of that of the WT ACP5Kir with KirCII (Figure 5A). The loca-
tions of these five positions were mapped onto the ACP5Kir
model (Figure 5B), which begins to define at least part of the
interaction epitope. In addition to those residues identified
from alanine scanning mutagenesis, the well-known and highly
conserved DSL motif comprising ACP5Kir residues D64, S65,
and L66 (see Table S1 for a list of carrier protein residues
involved in various protein interactions) can likely be included
in this epitope, given that the phosphopantetheinylation site is
embedded within this motif and previous experimental
evidence (Weissman et al., 2006).
Computational Docking
To provide further insight into the molecular basis of the KirCII
ACP specificity, a homology model for KirCII was obtained
using the SWISS-MODEL workspace (Arnold et al., 2006).Ltd All rights reserved
Figure 3. Cycloaddition Assay for KirCII:ACP Interactions
(A) KirCII-catalyzed trans-acylation and subsequent cycloaddition.
(B) In-gel fluorescence detection of a series of KirCII control assays. Coomassie blue image shows ACP loading in each reaction.
(C) Fluorescence intensity of labeled ACP5Kir in a series of control reactions using various trans-ATs or no enzyme.
(D) Fluorescence intensity of KirCII-labeled ACP5Kir as a function of time.
(E) Fluorescence intensity of labeled ACP5Kir as a function of KirCII concentration. Error bars represent the SD of the mean (n = 2).
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DEBS (34% identity to KirCII) was selected by SWISS-MODEL
as the template. Although KirCII functionally resembles the
trans-ATs DSZS and MCAT, the crystal structures of which are
known (Keatinge-Clay et al., 2003; Wong et al., 2011), these
two structures were not selected by SWISS-MODEL, likely
because of poor sequence identity with KirCII (27% and 22%
sequence identity to KirCII, respectively). This is in agreement
with phylogenetic analyses, which showed that KirCII is more
closely related to cis-ATs than to malonate-specific trans-ATs
(Musiol and Weber, 2012). In addition to the large and small AT
subdomains typical of trans-ATs, the modeled KirCII structure
also includes a KS-AT linker domain that is usually associated
with cis-acting AT domains from type I PKSs (Liew et al., 2012;
Tang et al., 2006). This prediction is in agreement with the
sequence length of KirCII (which is longer than that of DSZS
and MCAT), homology between the N-terminal portion of KirCII
and various cis-ATs (Figure S3), and secondary structure similar-
ity between the predicted KirCII KS-AT linker and structure of a
known linker domain (Figure S4). The KS-AT linker domain wasChemistry & Biology 21,included in our subsequent protein interaction studies, given
the possibility that the linker region participates in ACP recogni-
tion by cis-acting AT domains. Furthermore, the KS-AT linker
domain appears important for solubility of KirCII, given that a
truncated version of KirCII that lacks the linker could not be ex-
pressed in soluble form. The PatchDock (Schneidman-Duhovny
et al., 2005) and the ClusPro (Kozakov et al., 2013) servers were
then used for molecular docking simulations using the ACP5Kir
and KirCII models. Gratifyingly, both servers converged on
almost identical docking results, without any physical con-
straints. One of the top models was chosen on the basis of the
alanine scanningmutagenesis data described above (Figure 6A).
Overall, the docking model resembles that of the iterative type I
PKS DynE8 AT and ACP (Liew et al., 2012) and also that of the
AT3-ACP3 model from DEBS (Wong et al., 2010). ACP5Kir is pre-
dicted to sit in a large cleft formed by parts of the KS-AT linker
domain, as well as the small and large subdomains. Gratifyingly,
this model places the ACP phosphopantetheine attachment site
(S65) 20 A˚ away from the presumed active site catalytic Ser
(S203) of KirCII, and an active site tunnel can be identified that636–646, May 22, 2014 ª2014 Elsevier Ltd All rights reserved 639
Figure 5. Mapping the KirCII:ACP Interaction Epitope by Alanine
Scanning Mutagenesis
(A) trans-Acylation rates of holo-ACP5Kir alanine mutants with KirCII. Rates are
expressed as percentages of the activity with wild-type ACP5Kir. Wild-type
positions that were Ala/Gly were not mutated. Mutants that displayed <20%
the activity of the wild-type holo-ACP5Kir are highlighted red.
(B) trans-Acylation activities of ACP5Kir alanine mutants mapped onto an
ACP5Kir homology model ribbon diagram (left panel) and its computed surface
(right panel). Red, <20% activity; green, 20%–80% activity; yellow, >80%
activity; gray, not determined. Error bars represent the SD of the mean (n = 2).
Figure 4. ACP Specificity of KirCII
Activity of 3 mMKirCII with 30 mMeach kirromycin ACP and 300 mMAzEM-CoA
was determined by the cycloaddition assay. Error bars represent the SD of
the mean (n = 2).
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This model positions each of the five residues identified from
alanine scanning mutagenesis (H44, L45, R51, D60, and R70)
intimately at the interface between the ACP and KirCII. For
example, the carboxylate side chain of D60 of ACP5Kir is pre-
dicted to make a salt bridge with the terminus of the R410 side
chain of KirCII (Figure 6A). Interestingly, docking models of the
DynE8 AT:ACP (Liew et al., 2012), DEBS AT4:ACP4 (Tang
et al., 2006), and fungal nonreducing PksA:ACP complexes
(Bruegger et al., 2013), also implicate an Asp equivalent to D60
of ACP5Kir at the interface (Table S1). Notably, D60, along with
the nearby D64, appear to form a negatively charged group of
residues in loop I (L1) of ACP5Kir that interacts with three consec-
utive Arg residues from KirCII (R408–R410). Positively charged
residues of other ATs are often involved in ACP interactions
with an Asp residue analogous to ACP5Kir D64 (Keatinge-Clay
et al., 2003; Liew et al., 2012; Tang et al., 2006, 2007). In addition,
ACP5Kir R51 and R70, both judged as important for interaction
with KirCII by alanine scanning mutagenesis, are positioned to
interact with D98 and E395 of KirCII, respectively. Further, the
main chain nitrogen of ACP5Kir A48 is positioned for hydrogen
bonding with the hydroxyl of KirCII Y426. Another key predicted
interaction involves E245 and R69 from KirCII and ACP5Kir,
respectively (Figure 6A). To test the accuracy of this model, a se-
ries of KirCII mutants was constructed and assayed by using the
cycloaddition assay and ACP5Kir as substrate. The secondary
structure of each mutant matched closely to that of WT KirCII,
as judged by CD spectroscopy (Figure S5). The KirCII mutants
R408A, R409A, and R410A supported trans-acylation at slightly
lower rates compared with WT KirCII with ACP5Kir as substrate
(Figure 6B). Moreover, substitution of each Arg with Glu further
reduced the activity of each mutant. In addition, a triple mutant
where all three Arg residues (R408–R410) were mutated to Ala
displayed less than 10% trans-acylation activity compared with
wild-type KirCII, whereas no activity was detected for when all
three arginines were mutated to Glu (Figure 6B). These results
suggest that KirCII R408–R410 play a significant role in the inter-
action with ACP5Kir. Similarly, mutation of D98 of KirCII to Ala
reduced activity to just 30% of the WT KirCII activity (Figure 6B).640 Chemistry & Biology 21, 636–646, May 22, 2014 ª2014 ElsevierMutation of E245 to Ala reduced activity in comparison to WT
KirCII, whereas activity could not be detected when the same
residue was substituted with Arg (Figure 6B). Substitution of
KirCII E395 with Ala resulted in loss of activity, whereas substitu-
tion with Arg completely abolished activity. Similarly, the pre-
dicted importance of Y426 of KirCII was confirmed by mutagen-
esis (Figure 6B). These data are consistent with the electrostatic
contributions of these residues predicted on the basis of the
docking model and suggest that this set of residues is important
for controlling interactions between KirCII and ACP5Kir. Finally,
two surface residues more distant from the predicted interface
were also targeted. Substitution of D123 with Ala resulted in a
slight increase in activity with ACP5Kir as substrate, whereas
substitution of the same residue with Arg resulted in 50%
trans-acylation activity, compared with WT KirCII (Figure 6B).
Meanwhile, substitution of E170 with Ala resulted in small
decrease in activity with ACP5Kir as substrate, and substitution
of E170 with Arg resulted in 50% trans-acylation activity,
comparedwithWTKirCII, (Figure 6B). Thus, substitution of nega-
tively charged residues distal from the predicted interface with a
neutral amino acid has a small effect compared with equivalent
substitutions at predicted interface residues. Similarly, substitu-
tion at these distal sites with oppositely charged residues results
in only 2-fold decreased activity, compared with wild-type
KirCII, whereas such substitutions at residues predicted to be
involved in the KirCII epitope (e.g., R408E, R409E, R410E, and
E245R) led to dramatic decreases in activity compared withLtd All rights reserved
Figure 6. Docking Model of the KirCII:ACP5Kir Interaction
(A) A homology model for ACP5Kir was used as a ligand to dock with a
homology model for KirCII. See Experimental Procedures for details regarding
generation of the homology models. The KirCII large subdomain is shown in
light orange, the small subdomain of KirCII is shown in light pink, the KirCII
linker domain is green, and ACP5Kir is shown in teal. The HII
0 portion of LI of
ACP5Kir is highlighted red. Phosphopantetheinylation site of ACP5Kir and the
KirCII catalytic Ser are shown as spheres. For clarity, not every highlighted
residue is labeled.
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Chemistry & Biology 21,wild-type KirCII. Cumulatively, these data suggest that several
electrostatic interactions contribute to molecular recognition
between KirCII and its cognate ACP. Electrostatic surface
maps of KirCII and ACP5Kir highlight the charge complementarity
between several regions of the predicted interface (Figure 6C).
Mutagenesis of a Noncognate ACP
The docking model and mutagenesis data described above
suggest that a portion of L1, several C-terminal residues of
helix I (HI), and N-terminal residues of helix II (HII) are each
involved in the KirCII interaction epitope, whereas loop II (LII)
and helix III (HIII) of ACP5Kir do not make significant contributions
to the interaction with KirCII. To test this hypothesis and to
further define the ACP sequence elements required for ACP
specificity of KirCII, chimeras between ACP5Kir and a noncog-
nate ACP from kirromycin biosynthesis were constructed (Fig-
ures 7A and 7B). ACP10Kir was selected to contribute to these
chimeras, because this ACP shares the highest amino acid
sequence identity (35%) to ACP5Kir among the kirromycin
ACPs. Notably, the entire N-terminal half (L0-HI-LI) of ACP5Kir is
sufficient to provide robust recognition by KirCII when fused
with the C-terminal portion (HII-LII-HIII-LIII) of ACP10Kir. The cor-
responding chimera, ACP10Kir NA5, supported 50% activity
compared with the WT ACP5Kir, a 5-fold improvement in effi-
ciency compared with the noncognate ACP (Figure 7B). In
contrast, the reverse chimera that includes the N-terminal
portion of ACP10Kir and the C-terminal portion of ACP5Kir dis-
plays no detectable activity with KirCII (compare ACP10Kir NA5
and ACP10Kir CA5, Figure 7B). These data suggest that the
majority of the ACP5Kir:KirCII recognition features are located
in the N-terminal L0-HI-LI portion of ACP5Kir, in agreement with
the docking model and alanine scanning mutagenesis results.
In an attempt to further refine the putative interaction epitope,
a series of chimeras was designed that exchanged individual
secondary structure elements. Exchange of ACP10Kir HI or LI
with the corresponding structural element from ACP5Kir each
led to a 2-fold improvement in activity, compared with the WT
ACP10Kir (Figure 7B), and could not therefore recapitulate the
full activity of the ACP10Kir NA5 chimera that contained the entire
N-terminal portion of ACP5Kir. Interestingly, preceding HI of each
kirromycin ACP is a short sequence labeled L0 that is predicted
to form a random coil (Figure S6). As judged by sequence ho-
mology, this sequence element is not equivalent to the docking
domains postulated to play some role in protein interactions
between other trans-ATs and ACPs (Tang et al., 2004) (data
not shown). Substitution of the ACP10Kir L0 region with that
from ACP5Kir failed to significantly alter ACP specificity (see
ACP10Kir L0A5; Figure 7B), whereas deletion of L0 from ACP5Kir
resulted in an insoluble protein.(B) Mutational analysis of KirCII putative interface residues. Error bars repre-
sent the SD of the mean (n = 2).
(C)Electrostatic surfacepotentialmapsofKirCIIandACP5Kir arecalculatedusing
the PDB2PQR server (Dolinsky et al., 2007). Colors range from blue (positive) to
white (neutral) to red (negative). Fourkeyelectrostatic contactsare shownboxed;
the KirCII contacts are shown with boxes A (D98), B (R410), C (R409), and D
(E245), whereas those of ACP5Kir are shown with boxes A
0 (R51), B0 (D60), C0
(D64), andD0 (R69). The asterisk indicates the position of theKirCII active site Ser
and the ACP5Kir phosphopantetheinylation site. The surfaces are represented so
that if ACP5Kir is rotated 180
, the letters from each surface would match.
636–646, May 22, 2014 ª2014 Elsevier Ltd All rights reserved 641
Figure 7. Probing the ACP:KirCII Interaction Epitope by Mutagenesis of a Noncognate ACP
(A) Sequence logo for the kirromycin ACPs. Shown in gray and orange, respectively, are the amino acids at selected positions of ACP5Kir and ACP10Kir. The
asterisk indicates the phosphopantetheinylation site. Positions discussed in the text are highlighted. Boundaries between each secondary structure element are
also shown. For brevity, N- and C-terminal loop regions (L0 and LIII) are not shown. L0 is the region preceding HI, and LIII is the region following HIII.
(B) Scheme showing contribution of ACP5Kir and ACP10Kir to each chimera or mutant (left panel), and activities of WT, chimeric, andmutant kirromycin ACPswith
KirCII (right panel). The rates are expressed as percentages of the activity with WT holo-ACP5Kir.
(C) Activities of WT and mutant ACP6DEBS with KirCII, expressed as percentages of the activity with WT holo-ACP5Kir. See Experimental Procedures for reaction
and assay conditions. Error bars represent the SD of the mean (n = 2).
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ACP10Kir are poorly conserved among kirromycin ACPs, as
judged by alignment of their amino acid sequences (Figure 7A
and Figure S7). Moreover, four of these poorly conserved posi-
tions correspond to residues that were previously highlighted
by alanine scanning mutagenesis of ACP5Kir (H44, R51, D60,
and R70). Accordingly, we hypothesized that some of these
poorly conserved residues, perhaps including some from the
alanine scanning mutagenesis set, might dictate the ACP spec-642 Chemistry & Biology 21, 636–646, May 22, 2014 ª2014 Elsevierificity of KirCII. To test the contribution of these poorly conserved
positions in controlling specificity, a panel of 13 mutants was
constructed that substituted each selected residue within HI,
LI, and HII of ACP10Kir with the corresponding residue from
ACP5Kir (Figure 7A). With respect to positions highlighted
by alanine scanning mutagenesis, substitution at I37 and E53
in ACP10Kir (equivalent to H44 and D60 in ACP5Kir, Figure 7A)
provided only small changes to the trans-acylation activity,
compared with wild-type ACP10Kir (see I37H and E53D,Ltd All rights reserved
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(corresponding to positions R51 and R70 in ACP5Kir, Figure 7A)
each display approximately 2-fold higher activity with KirCII,
compared with wild-type ACP10Kir, underscoring the impor-
tance of these two previously highlighted positions for recogni-
tion by KirCII. Interestingly, substitution of ACP10Kir Q62 with
Arg (equivalent to R69 in ACP5Kir) failed to improve activity
with KirCII, compared with WT ACP10Kir, even though this resi-
due is adjacent to the equivalent of R70 in ACP5Kir. This result
is entirely consistent with the alanine scanning mutagenesis
data, which show that of the R69/R70 pair in ACP5Kir, only sub-
stitution at R70 is detrimental to activity with KirCII. Presumably,
R70 in ACP5Kir contributes more to the interaction with KirCII
than the neighboring R69, even though R69 is predicted to
interact with KirCII via E245 (Figures 6A–6C). Perhaps mutation
to Ala at R69 can be better compensated by other side chain
rearrangements than Ala substitution at R70. Notably, aside
from ACP5Kir, Arg is never found at residue 69 among the kirro-
mycin ACPs, and this residue is most frequently Leu or Val (Fig-
ure 7A and Figure S7). Similarly, at residue 70, Arg is found only
three times among all 15 kirromycin ACP sequences and is most
often the oppositely charged Glu (Figure 6A and Figure S7). The
most active ACP10Kir single amino acid exchanges were those at
positions F51 and Y54 (equivalent to L58 and V61 in ACP5Kir) and
do not correspond to positions highlighted by our alanine scan-
ning mutagenesis. Substitution at these two positions with the
equivalent residue from ACP5Kir, Leu and Val, respectively, sup-
ported activity 5-fold higher than WT ACP10Kir (Figure 7B).
Consistent with these data, mutagenesis of the ACP5Kir residue
corresponding to ACP10Kir Y54 resulted in amutant that showed
only 21% the activity of WT ACP5Kir (ACP5Kir V61A; Figure 5A).
Intriguingly, the ACP5Kir residue equivalent to ACP10Kir F51
(L58) was not expressed in soluble form when mutated to Ala
as part of the previous surface mutagenesis and was therefore
not highlighted by the surface mutagenesis data. Interestingly,
ACP5Kir L58 and V61 are not well conserved among the kirromy-
cin ACPs (Figure 7A and Figure S7). For example, residue 58 is
most often Phe (as in ACP10Kir F51) and is Leu in only four of
the kirromycin ACP sequences. Residue 61 is usually Leu or
Tyr (as in ACP10Kir Y54) among the kirromycin ACPs and is Val
only in ACP5Kir. Combination of both F51L and Y54V in ACP10Kir
actually resulted in a slight decrease in trans-acylation activity
compared with either the F51L or Y54Vmutant (Figure 7B). How-
ever, exchange of a portion of a LI sequence in ACP10Kir that
included F51 and Y54 with that from ACP5Kir (HII
0, corresponding
to V57–D60 in ACP5Kir), resulted in a chimera with 5-fold the ac-
tivity of wild-type ACP10Kir (ACP10Kir-H*; Figure 7B). Thus, the
precise identities of residues within this short helix are critical
for maintaining maximal activity with KirCII. Together, these
data suggest that in ACP5Kir, Arg residues at positions 51/70
and Leu/Val at positions 58/61, respectively, are required but
not totally sufficient for recognition by KirCII.
Reprogramming KirCII Interactions toward a
Noncognate ACP from the Erythromycin PKS
Some trans-ATs have been shown to be promiscuous toward the
ACP substrate and can utilize ACPs from different biosynthetic
pathways (Walker et al., 2013; Wong et al., 2010). The conclu-
sions that Arg is required at positions 51/70 of ACP5Kir andChemistry & Biology 21,that Leu and Val are required at positions 58 and 61 led us to
predict whether ACPs from other biosynthetic systems would
serve as substrates for KirCII. For example, ACP6 from DEBS
includes Asp and Gly at positions equivalent to 51/70 of ACP5Kir,
whereas at residues equivalent to ACP5Kir 58 and 61, Phe and
Leu are present in the ACP6DEBS, respectively. Accordingly, we
predicted that ACP6DEBS would not serve as an efficient
substrate for KirCII. This hypothesis was tested by carrying out
the cycloaddition assay using AzEM-CoA, KirCII, and holo-
ACP6DEBS. As predicted, WT holo-ACP6DEBS was not a detect-
able substrate for KirCII (Figure 7C). Given that the ACP10Kir
mutation F51L led to improved trans-acylation activity with KirCII
(Figure 7B), compared with the wild-type ACP10Kir, and that the
equivalent residue in ACP6DEBS is also Phe (F38), we proposed
that introduction of leucine at position 38 of ACP6DEBS would
improve the trans-acylation efficiency of this noncognate
ACP with KirCII. To test this notion, the mutant ACP6DEBS F38L
was constructed, converted to the holo-form, and assayed
with KirCII. Remarkably, and in complete contrast to wild-type
ACP6DEBS, the F38L mutant was a detectable substrate for
KirCII, and this substitution improved trans-acylation activity at
least 14-fold compared with WT ACP6DEBS (Figure 7C). This
shows that the activity of a trans-AT has been rationally engi-
neered toward a noncognate carrier protein.
DISCUSSION
An improved understanding of protein interactions is required
to overcome limitations related to the ACP specificity of trans-
ATs. Although structural studies of trans-ATs that utilize
malonyl-CoA have slowly emerged (Keatinge-Clay et al., 2003;
Wong et al., 2011), nothing is known regarding the structure
and ACP interactions of trans-ATs with unusual acyl-CoA spec-
ificities. In this study, we harnessed the acyl-CoA promiscuity of
KirCII (Koryakina et al., 2013b) to rapidly probe its interaction
with a series of ACPs. The expected cognate protein, ACP5Kir,
was found to be the preferred substrate for KirCII, whereas the
enzyme was capable of utilizing other kirromycin ACPs to a
lesser extent. These data suggest that programmed protein
interactions could play a role in controlling extender unit incorpo-
ration into kirromycin but do not rule out the role of downstream
substrate specificity or editing functions.
The specificity of KirCII for ACP5Kir, coupled with the relatively
high sequence homology between the other kirromycin ACPs,
provided an opportunity to identify ACP elements that contribute
to trans-AT specificity. Alanine scanning mutagenesis identified
several ACP residues that, when mutated to Ala, almost
completely abolished activity with KirCII. Interestingly, this result
contrasts with alanine scanningmutagenesis of themalonyl-CoA
specific, yet ACP promiscuous trans-AT, DSZS (Wong et al.,
2011), which revealed only two positions that were sensitive
to substitution. Computational prediction of the interaction be-
tween ACP5Kir and KirCII provided a model that was consistent
with the alanine scanning mutagenesis data. The KS-AT linker
domain, the large AT subdomain, and small AT subdomain of
KirCII are all predicted to be involved in ACP recognition. The
KS-AT linker domain of KirCII may contribute to the strict ACP
specificity of KirCII, given that structures of the ACP promiscu-
ous trans-ATs MCAT and DSZS do not include this domain. In636–646, May 22, 2014 ª2014 Elsevier Ltd All rights reserved 643
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model (Figure 6A), is most often Glu or Ala in other ACPs.
Furthermore, the position equivalent to ACP5Kir R51 in other
ACPs is not predicted to be involved in interactions with trans-
ATs or other interacting domains (Table S1). Additional ACP5Kir
residues that appear to contribute to recognition by KirCII that
are also not identified by other protein interaction studies include
R56 and R70. Notably though, some predicted KirCII:ACP5Kir
interactions involve ACP residues that have been implicated in
other protein interaction studies. For example, D64 is part of
the highly conserved DSL motif and is predicted to be involved
in diverse interactions between various PKS domains. Another
key residue, D60, is often Asp or Glu in other ACPs and has
been implicated in protein interactions between other ATs. Curi-
ously, D60 locates to a short helical turn (HII
0 in Figures 5B and
6A) in the middle of LI of ACP5Kir. Intriguingly, short helical turns
similar to HII
0 have been proposed to contribute to other ACP in-
teractions. For example, a short helix located within LII has been
proposed to flag ACPs for b-branching in polyketide biosyn-
thesis (Haines et al., 2013). In another example, a similarly short
helical turnwas implicated in the specific interaction between the
curacin A ACPI and halogenase embeddedwithin the CurAmod-
ule (Busche et al., 2012). Further, in the nonreducing PKS PksA
ACP, an aspartate equivalent to ACP5Kir D60, located in a small
helical turn, is predicted to make a key electrostatic interaction
with the KS domain of PksA (Bruegger et al., 2013). Notably,
we found that recognition by KirCII was very sensitive to amino
acid substitution in the HII
0 region of ACP5Kir. Individual substitu-
tions at two key hydrophobic sites in this region were sufficient to
improve the activity of ACP10Kir 5-fold with KirCII. Moreover, we
established that amino acid substitution at one site within this
region of an ACP from an entirely different biosynthetic system
was sufficient to convert a completely inactive ACP into a robust
substrate. Thus, the overall shape, position of D60, or dynamics
of the HII
0 region may be important for specifying the activity of a
given ACP with KirCII. In fact, hydrophobic packing within a
similar short helical turn of ACP-mupA3a frommupirocin biosyn-
thesis was recently found to contribute significantly to recogni-
tion by the cognate trans-acting b-branching domain, MupH
(Haines et al., 2013). In addition to our extensive mutagenesis
of the kirromycin ACPs, the role of several KirCII residues was
probed by substituting key charged residues with neutral or
oppositely charged amino acids. The results were consistent
with the docking model and suggested that charged residues
at the KirCII:ACP5Kir interface contribute to the strict ACP spec-
ificity of KirCII by forming key electrostatically matched interac-
tions. Furthermore, these data suggest that KirCII harnesses a
larger number of electrostatic interactions with its cognate
ACP than that of ACP promiscuous trans-ATs such as MCAT
and DSZS. Thus, a picture is emerging whereby the ACP speci-
ficity of KirCII is a consequence of a large and unique set of
charged and hydrophobic residues at the ACP5Kir surface.
Together, these data describe the interaction epitope between
a non-malonyl-utilizing trans-AT and cognate ACP.
Critically, those ACP5Kir residues involved in recognition by
KirCII would have been difficult to identify from sequence anal-
ysis alone. For example, several charged ACP5Kir residues that
are poorly conserved among the kirromycin ACPs are not impor-
tant for KirCII specificity (e.g., R34, D35, and R38). Similarly, a644 Chemistry & Biology 21, 636–646, May 22, 2014 ª2014 Elsevierpair of Arg residues in HII of ACP5Kir (R73/R74) are quite conspic-
uous and might have been assumed to be important for KirCII
recognition by comparison to other kirromycin ACPs, yet neither
residue was found to be important herein.
Cumulatively, our data provide a platform for harnessing the
acyl-CoA promiscuity of KirCII for diversification of polyketides.
For example, with knowledge of the ACP5Kir:KirCII epitope in
hand, ACPs from other biosynthetic systems might now be iden-
tified by sequence comparison that could be recognized by
KirCII. In addition, the insight obtained here will enable strategies
for further engineering trans-AT:ACP interactions. It is envi-
sioned that residues in noncognate ACPs that correspond to
those recognized by KirCII (or other trans-ATs) could be targeted
for mutagenesis and screening or selection, by utilizing the
cycloaddition assay in combination with cell surface display.SIGNIFICANCE
Trans-ATs offer exciting possibilities for polyketide diversifi-
cation, especially given the potential extender unit promis-
cuity of KS domains (Koryakina et al., 2013a). However, little
is known regarding the ACP or extender unit specificity of
many trans-ATs. Putative ACP recognition features have
emerged only with those trans-ATs that naturally utilize ma-
lonyl-CoA, with limited potential to introduce other extender
units into polyketides. Understanding the features of ACPs
that allow recognition by a cognate trans-AT is a crucial first
step that may enable manipulation of trans-AT ACP speci-
ficity. We proposed that the trans-AT KirCII only interacts
with a single ACP within the parent kirromycin biosynthetic
assembly line, and this would provide an opportunity to
probe theACP features required for recognitionbyauniquely
acyl-CoA promiscuous trans-AT. We recognized that the
ability of KirCII to utilize substrates modified with chemical
handles for click chemistry could be leveraged to provide a
rapid and convenient assay for measuring the activity of
KirCII. Accordingly, the activity of KirCII toward each kirro-
mycin ACP was measured, providing evidence that KirCII
interacts specificallywith theexpectedcognateACP.Acom-
bination of ACP surface mutagenesis, docking simulations,
KirCII mutagenesis, and substitutions of amino acids and
structural elements led to the identification of several key
electrostatic interactions that define theACP5Kir:KirCII inter-
action epitope.Remarkably, this insight enabledengineering
acompletely noncognateACP into adetectable substrate for
KirCII via the introduction of a single amino acid substitution.
Our data combined with previous studies highlight the
importance of small helical turns locatedwithin loop regions
that connect the larger helices that form the basis of all ACP
structures. In the long term, an improved understanding of
the features that allow recognition of an ACP by trans-ATs
can be used as a foundation for designing strategies that
allow the diversification of polyketides.EXPERIMENTAL PROCEDURES
General
Unless otherwise stated, all materials and reagents were of the highest grade
possible and purchased from Sigma. Isopropyl b-D-thiogalactoside (IPTG)Ltd All rights reserved
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from Promega. Primers were ordered from Integrated DNA Technologies.
Analytical high-performance liquid chromatography (HPLC) was performed
on a Varian ProStar system.
Cloning and Expression of Kirromycin ACPs
The genes encoding kirromycin ACPs were amplified from cosmids 1C24
and 2C23 (Weber et al., 2008) using HotStar HiFidelity polymerase (QIAGEN)
and the primers listed in Table S2. Fragments were cloned in pET30Ek/LIC
(Novagen/Merck Millipore) using the manufacturer’s protocol. Plasmids
harboring each kirromycin ACP were cotransformed with plasmid pSU20-
Sfp into E. coli BL21(DE3). A single colony was then used to inoculate 3 ml
of Luria Burtani (LB) medium containing 34 mg/ml chloramphenicol and
50 mg/ml kanamycin that was cultured overnight at 37C with shaking at
250 rpm. The overnight culture was used to inoculate 300 ml of LB medium
containing the same antibiotics and was then incubated at 37C at 250 rpm
until the optical density 600 had reached 0.6. Protein expression was
induced by the addition of 0.5 mM IPTG and was then incubated at 18C at
250 rpm for 18 hr.MS analysis of initial trials indicated that in vivo phosphopan-
tetheinylation yielded significant but incomplete conversion to the holo-form.
To drive phosphopantetheinylation to completion, an in vitro conversion to
the holo-form was also performed using cleared cell extract from each ACP
overexpression. Briefly, cleared cell extract prepared from 300 ml of cell
culture was mixed with 40 ml of 50 mM CoA and was incubated at room tem-
perature for 4 hr and then kept at 4C overnight. The proteins were then puri-
fied by nickel-nitrilotriacetic acid chromatography largely as previously
described (Musiol et al., 2013), except the batch purification method was
used. MS analysis showed full conversion to the holo ACP for every ACP
(Figure S1).
Cloning and Expression of Sfp, KirCII, DSZS, and MCAT
Cloning and expression of Sfp, KirCII, DSZS, and MCAT were performed as
previously described (Koryakina et al., 2013b).
Chemoenzymatic Synthesis of Azidoethylmalonyl-CoA
Chemoenzymatic synthesis of azidoethylmalonyl-CoA was performed in
400 ml of reaction mixture containing 100 mM sodium phosphate (pH 7),
MgCl2 (2 mM), ATP (6 mM), coenzyme A (3 mM), azidoethyl malonate
(15mM) (Koryakina et al., 2013b), andmutantMatB (20 mg) at 25C. Production
of azidoethylmalonyl-CoA was confirmed by HPLC. Aliquots were removed
after overnight incubation, quenched with an equal volume of ice-cold meth-
anol, and centrifuged at 10,000 3 g for 10 min, and cleared supernatants
were used for HPLC analysis on a Varian ProStar HPLC system. A series of
linear gradients was developed from 0.1% trifluoroacetic acid (A) in water to
methanol (HPLC grade, B) using the following protocol: 032 min, 80% B;
3235 min, 100% A. The flow rate was 1 ml/min, and the absorbance was
monitored at 254 nm using Pursuit XRs C18 column (250 mm 3 4.6 mm;
Varian).
General Procedure for Strain-Promoted Azide-Alkyne Cycloaddition
Assay
The strain-promoted azide-alkyne cycloaddition assay was performed in a
total volume of 6 ml and contained 4 ml of KirCII assay mixture containing
20 mMACP5Kir and 2 ml of 600 mMof DIBO-Alexa Fluor 647 (Life Technologies).
The reaction was incubated in dark at room temperature with gentle agitation
for 1 hr. The reactions were boiled after addition of protein loading dye for 5min
before analysis by SDS-PAGE. The gels were scanned using a Typhoon 7000
phosphoimager to determine the intensity of DIBO-labeled proteins bands.
The bands were quantified by ImageQuant TL software (GE Life Sciences),
and the rubber-band background subtraction method was applied.
KirCII Titration Assay
KirCII titration assay was performed in 10 ml of reaction mixture containing
50 mM Tris-HCl (pH 7.5), 50 mM MgCI2, 300 mM of azidoethylmalonyl-CoA,
50 mM holo ACP5Kir, and KirCII at room temperature for 20 min. 4 ml of KirCII
reaction mixture was then removed for strain-promoted azide-alkyne cycload-
dition assay.Chemistry & Biology 21,KirCII Time-Course Assay
KirCII time-course assay was performed in 70 ml of reaction mixture containing
50 mM Tris-HCl (pH 7.5), 50 mM MgCI2, 300 mM of azidoethylmalonyl-CoA,
30 mM holo ACP5Kir, and 1 mM KirCII at room temperature. Aliquots were
removed at different time points and stored at 80C before being used for
strain-promoted azide-alkyne cycloaddition assay.
Alanine Scanning Mutagenesis of ACP5Kir
Primers for alanine scanning mutagenesis of ACP5Kir were designed with
lengths between 25 and 30 bp, whereas melting temperatures were between
70C and 75C. Site-directed mutagenesis was performed following the
QuikChange protocol (Agilent Technologies).
KirCII assay using each ACP5Kir alanine scanning mutant was performed in
10 ml of reaction mixture containing 50 mM Tris-HCl (pH 7.5), 50 mM MgCI2,
300 mM of azidoethylmalonyl-CoA, 30 mM holo ACP5Kir, and 3 mM KirCII at
room temperature for 1 hr. An aliquot (4 ml) of the reaction mixture was then
removed and assayed using the strain-promoted azide-alkyne cycloaddition
procedure.
Circular Dichroism
Circular dichroism (CD) measurements were performed with a JASCO 810 CD
Spectropolarimeter. Samples for CD were buffer exchanged into CD buffer
(10 mM potassium phosphate, 50 mM sodium sulfate, pH 7.4), and the con-
centration of samples was 0.2 mg/ml. Spectra from 190 to 260 nm were
scanned at a step of 0.5 nm at 20C in a 0.1-cm cuvette, with ten repeats.
The scan speed was 100 nm/min.
Homology Model of ACP5Kir and KirCII
Homology models for ACP5Kir and KirCII were generated using the automated
mode of the SWISS-MODEL workspace (http://swissmodel.expasy.org/). The
template used for ACP5Kir was PDB ID 1DV5 (Volkman et al., 2001), and the
sequence identity between the template and ACP5Kir was 26%. The template
for KirCII was PDB ID 2QO3 (Tang et al., 2007), and the sequence identity
between template and KirCII was 34%. Based on QMEAN z scores (Benkert
et al., 2011), the quality for the homology models is good.
Site-Directed Mutagenesis and Chimeragenesis of ACPs and KirCII
Plasmid pET30-KirACP10 was used as a template for mutagenesis of
ACP10Kir. For mutagenesis of KirCII, plasmid pET52-KirCII was used (Musiol
et al., 2011). ACP and KirCII amino acid substitutions were performed using
the QuikChange protocol (Agilent Technologies). Multiple-template-based
sequential PCR (Shan and Lynch, 2010) was used for construction of ACP
chimeras. E. coli DH5a was used for plasmid amplification. All mutations
were confirmed by DNA sequencing. Specific primer sequences used for
construction of ACP10Kir/ACP5Kir chimeras can be found in the supplemental
information (Table S3).
SUPPLEMENTAL INFORMATION
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